Patent details
EP1893747
Title:
ISOLATED CELLS AND POPULATIONS COMPRISING SAME FOR THE TREATMENT OF CNS DISEASES
Basic Information
- Publication number:
- EP1893747
- PCT Application Number:
- PCT/IL/2006/000699
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP067661017
- PCT Publication Number:
- WO/2006/134602
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ISOLATED CELLS AND POPULATIONS COMPRISING SAME FOR THE TREATMENT OF CNS DISEASES
- French Title of Invention:
- CELLULES ISOLEES ET POPULATIONS COMPRENANT CES CELLULES POUR LE TRAITEMENT DE MALADIES DU SNC
- German Title of Invention:
- ISOLIERTE ZELLEN UND DIESE ENTHALTENDE POPULATIONEN ZUR BEHANDLUNG VON KRANKHEITEN DES ZNS
- SPC Number:
-
Dates
- Filing date:
- 18/06/2006
- Grant date:
- 03/09/2014
- EP Publication Date:
- 03/09/2014
- PCT Publication Date:
- 21/12/2006
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 05/03/2008
- EP B1 Publication Date:
- 03/09/2014
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 18/06/2015
- Expiration date:
- 18/06/2026
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 18/06/2006
-
-
- Name:
- Ramot at Tel Aviv University Ltd.
- Address:
- P.O. Box 39296, 6139201 Tel Aviv, Israel (IL)
Inventor
1
- Name:
- OFFEN Daniel
- Address:
- Israel (IL)
2
- Name:
- BAHAT-STROMZA Merav
- Address:
- Israel (IL)
3
- Name:
- MELAMED Eldad
- Address:
- Israel (IL)
Priority
- Priority Number:
- 690879 P
- Priority Date:
- 16/06/2005
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
-
C12N 5/0775;
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-
Filing date |
Document type |
Number of pages |